Literature DB >> 17458526

[Depression in Parkinson's disease. Assessment and treatment].

S Brand1, R Dodel, M Hautzinger, G Gründer, A Althaus, F Schneider.   

Abstract

With a prevalence of 40%, depression is the most frequent psychiatric diagnosis in Parkinson's disease. Quality of life in Parkinson's patients is severely restricted. There is still no clear evidence concerning the link between these disorders - findings exist that indicate common neurodegenerative processes. At the same time depression seems to develop as a dysfunctional coping reaction to the motoric, emotional, and social restrictions of Parkinson's disease. The authors point out particular features of the depressive symptom profile in patients with Parkinson's disease and recommend a step-by-step approach to assessing depression: screening, assessment by means of the ICD-10 criteria, quantitative evaluation of depressivity, and assessment of suicidality. A survey of current treatment options is provided: pharmacological, somatic, and psychological approaches are introduced and evaluated with respect to effectiveness in this special group of patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458526     DOI: 10.1007/s00115-007-2292-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

Review 1.  Therapeutic application of repetitive transcranial magnetic stimulation: a review.

Authors:  E M Wassermann; S H Lisanby
Journal:  Clin Neurophysiol       Date:  2001-08       Impact factor: 3.708

2.  [Data supporting quality circle management of inpatient depression treatment].

Authors:  S Brand; M Härter; P Sitta; D van Calker; R Menke; A Heindl; K Herold; R Kudling; C Luckhaus; U Rupprecht; Dirk Sanner; D Schmitz; E Schramm; M Berger; W Gaebel; F Schneider
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

Review 3.  Prevalence and incidence of Parkinson's disease in Europe.

Authors:  Sonja von Campenhausen; Bernhard Bornschein; Regina Wick; Kai Bötzel; Cristina Sampaio; Werner Poewe; Wolfgang Oertel; Uwe Siebert; Karin Berger; Richard Dodel
Journal:  Eur Neuropsychopharmacol       Date:  2005-08       Impact factor: 4.600

Review 4.  Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

Review 5.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions.

Authors:  Michael Bauer; Peter C Whybrow; Jules Angst; Marcio Versiani; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2002-04       Impact factor: 4.132

Review 6.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.

Authors:  Michael Bauer; Peter C Whybrow; Jules Angst; Marcio Versiani; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2002-01       Impact factor: 4.132

Review 7.  Sleep deprivation therapy in depressive illness and Parkinson's disease.

Authors:  E M Demet; A Chicz-Demet; J H Fallon; K N Sokolski
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1999-07       Impact factor: 5.067

8.  Factors impacting on quality of life in Parkinson's disease: results from an international survey.

Authors: 
Journal:  Mov Disord       Date:  2002-01       Impact factor: 10.338

Review 9.  Therapies for depression in Parkinson's disease.

Authors:  Ghazi-Noori Shabnam; Chung Th; Deane Kho; Rickards H; Clarke Ce
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  [Subjectively-perceived inappropriate treatment of depressed patients in general and psychiatric practice].

Authors:  Frank Schneider; Martin Härter; Sandra Kratz; Isaac Bermejo; Christoph Mulert; Ulrich Hegerl; Wolfgang Gaebel; Mathias Berger
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2003-11
View more
  4 in total

1.  [Is there evidence that depression screening benefits patients with medical illness?: not yet].

Authors:  B D Thombs; A Körner
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

2.  [Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany].

Authors:  O Riedel; R Dodel; G Deuschl; H Förstl; F Henn; I Heuser; W Oertel; H Reichmann; P Riederer; C Trenkwalder; H U Wittchen
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

3.  Lewy body dementia and Parkinson's disease with dementia.

Authors:  Richard Dodel; Ilona Csoti; Georg Ebersbach; Gerd Fuchs; Matthias Hahne; Wilfried Kuhn; Matthias Oechsner; Wolfgang Jost; Heinz Reichmann; Jörg B Schulz
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

4.  MAO-inhibitors in Parkinson's Disease.

Authors:  Peter Riederer; Gerd Laux
Journal:  Exp Neurobiol       Date:  2011-03-31       Impact factor: 3.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.